Match!
Andrew J. Massey
DNA damageProgrammed cell deathCHEK1PI3K/AKT/mTOR pathwaymTORC1
1Publications
1H-index
11Citations
What is this?
Publications 1
Newest
#1Andrew J. MasseyH-Index: 1
#2Peter Stephens (Newcastle University)H-Index: 5
Last. Nicola J. Curtin (Newcastle University)H-Index: 57
view all 6 authors...
Abstract Background Chk1 inhibitors are currently under clinical evaluation as single agents and in combination with cytotoxic chemotherapy. Understanding determinants of sensitivity and novel combinations is critical for further clinical development. Methods Potentiation of mTOR inhibitor cytotoxicity by the Chk1 inhibitor V158411 was determined in p53 mutant colon cancer cells. DNA damage response, expression levels of repair proteins, cell cycle effects and the contribution of alternative DSB...
11 CitationsSource
1